These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension. Sağ S; Yeşilbursa D; Güllülü S Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528 [TBL] [Abstract][Full Text] [Related]
24. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158 [TBL] [Abstract][Full Text] [Related]
26. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327 [TBL] [Abstract][Full Text] [Related]
27. Portopulmonary hypertension and hepatorenal syndrome. Two faces of the same coin. Zardi EM; Zardi DM; Giorgi C; Chin D; Dobrina A Eur J Intern Med; 2017 Sep; 43():22-27. PubMed ID: 28583409 [TBL] [Abstract][Full Text] [Related]
28. Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation. Vionnet J; Yerly P; Aubert JD; Pascual M; Aldenkortt F; Berney T; Giostra E; Moradpour D; Schiffer E Transplantation; 2018 May; 102(5):e194. PubMed ID: 29485510 [No Abstract] [Full Text] [Related]
29. Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta-Analysis. Deroo R; Trépo E; Holvoet T; De Pauw M; Geerts A; Verhelst X; Colle I; Van Vlierberghe H; Fallon MB; Raevens S Hepatology; 2020 Nov; 72(5):1701-1716. PubMed ID: 32017176 [TBL] [Abstract][Full Text] [Related]
30. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis. Molnar C; Alber H; Colleselli D; Vogel W; Kähler CM Wien Klin Wochenschr; 2004 Sep; 116(17-18):627-30. PubMed ID: 15515882 [TBL] [Abstract][Full Text] [Related]
31. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. Yang YY; Lin HC; Lee WC; Hou MC; Lee FY; Chang FY; Lee SD J Gastroenterol; 2001 Mar; 36(3):181-6. PubMed ID: 11291881 [TBL] [Abstract][Full Text] [Related]
33. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation]. Chávez-Tapia NC; Uribe M; López E Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842 [TBL] [Abstract][Full Text] [Related]
35. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation? Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213 [TBL] [Abstract][Full Text] [Related]
36. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension. Legros L; Chabanne C; Camus C; Fournet M; Houssel-Debry P; Latournerie M; Jezequel C; Rayar M; Boudjema K; Guyader D; Bardou-Jacquet E Dig Liver Dis; 2017 Mar; 49(3):301-307. PubMed ID: 27840058 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330 [TBL] [Abstract][Full Text] [Related]
38. [Portopulmonary hypertension]. Halank M; Miehlke S; Kolditz M; Hoeffken G Z Gastroenterol; 2005 Jul; 43(7):677-85. PubMed ID: 16001350 [TBL] [Abstract][Full Text] [Related]
39. Novel use of sildenafil in the treatment of portopulmonary hypertension. Chua R; Keogh A; Miyashita M J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756 [TBL] [Abstract][Full Text] [Related]
40. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]